Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|June 6, 2024
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanomaJoseph J Sacco, Richard D Carvajal, Marcus O Butler, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Recent advances in genitourinary tumors: A review focused on biology and systemic treatmentAránzazu González Del Alba, José Ángel Arranz, Javier Puente, et al.
Cancer|August 18, 2016
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodiesAlain P Algazi, Katy K Tsai, Alexander N Shoushtari, et al.
Science Advances|March 15, 2023
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistanceAndrea Alegre-Martí, Alba Jiménez-Panizo, Adrián Martínez-Tébar, et al.
Nature Communications|July 15, 2021
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockadeOctavio A Romero, Andrea Vilarrubi, Juan J Alburquerque-Bejar, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2022
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trialJoan Carles, Teresa Alonso-Gordoa, Begoña Mellado, et al.
Nature Medicine|January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Kobe C Yuen, Silke Gillessen, et al.
European Urology|November 6, 2020
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based TreatmentVicenç Ruiz de Porras, Xieng C Wang, Luis Palomero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous CarcinomaAdrià Bernat-Peguera, Juan Navarro-Ventura, Laura Lorenzo-Sanz, et al.
European Urology Oncology|June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort DEvan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
Pageof 7